GLOBAL FUND, PEPFAR ANNOUNCE COORDINATED EFFORT TO REACH 2 MILLION PEOPLE WITH LENACAPAVIR FOR PREP TO SIGNIFICANTLY REDUCE GLOBAL HIV INFECTIONS

PEPFAR RELEASE The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and the United States President’s Emergency Plan for AIDS Relief (PEPFAR) have joined forces with the Children’s Investment Fund Foundation (CIFF) and the Bill & Melinda Gates Foundation (BMGF) to announce today a coordinated effort that will rapidly provide affordable and…

“These filoviruses are always re-emerging” say East African scientists working on vaccine for Sudan Ebola strain

Two years after the Sudan Ebolavirus disrupted health systems in Uganda, killing 55 people, scientists in the region have started phase 2 trials on a new candidate vaccine. 19 December 2024 by John Agaba Dr Betty Mwesigwa was driving to the Makerere University Walter Reed Program (MUWRP) offices in Kampala  in 2022, when a news alert…

Could the TB vaccine in phase 3 trials in Malawi be a game-changer?

7,700 Malawians died of tuberculosis in 2021 alone. Researchers, health officials and survivors hope a vaccine designed for adults could make all the difference. 19 December 2024 by Rabson Kondowe In December 2023, Amosi Kapoti suspected that something was terribly wrong with him. He had lost weight and developed a prolonged fever, and had been coughing…